See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

DHTV
Popular
Top Rated

Related Complications & Care Videos on Diabetes Health TV

ARKRAY introduces The GLUCOCARD™ X-METER

Becky Brown

ARKRAY introduces The GLUCOCARD™ X-METER

Sugar Free Ice Cream and Treats from Blue Bunny

Laura Sprague

Sugar Free Ice Cream and Treats from Blue Bunny

Injection Site Awareness Week

Dr. Stuart Bootle, MB ChB

Injection Site Awareness Week

Triglycerides

Updated 50 weeks ago
Type 2: Finnish Study Says Statins Users Run Higher Diabetes Risk
Oct 13, 2012 | 
Recently, a Finnish study evaluated nearly 2,800 nondiabetic individuals, close to 500 of whom were using statins, after they had participated in a year of lifestyle interventions intended to improve their glucose metabolism. (Statins are lipid-lowering drugs that inhibit an enzyme crucial to the production of serum cholesterol; high cholesterol is associated with hardening of the arteries and cardiovascular problems.) The study was conducted by Dr. Nina Rautio and colleagues at Pirkanmaa Hospital in Tampere, Finland.
Novo Says Early Use of Victoza Aids Type 2 Control
Oct 2, 2011 | 
News from Danish pharmaceutical manufacturer Novo Nordisk reinforces the growing trend toward using a two-drug combination in the early treatment of type 2 diabetes. (See "A Conversation About Janumet and Earlier Combination Therapy for Type 2 Diabetes" for more discussion about this phenomenon.) In a study it released in Lisbon, Portugal, at the recent meeting of the European Association for the Study of Diabetes, Novo said that combining its recently released drug Victoza® (liraglutide) with another drug early in therapy helps recently diagnosed type 2s achieve greater blood glucose control than they can with a single drug.
DHTV
Popular
Top Rated

Related Complications & Care Videos on Diabetes Health TV

ARKRAY introduces The GLUCOCARD™ X-METER

Becky Brown

ARKRAY introduces The GLUCOCARD™ X-METER

Sugar Free Ice Cream and Treats from Blue Bunny

Laura Sprague

Sugar Free Ice Cream and Treats from Blue Bunny

Injection Site Awareness Week

Dr. Stuart Bootle, MB ChB

Injection Site Awareness Week

The EndoBarrier Is Approved for Sale in the EU
Apr 1, 2011 | 
As we wrote back in 2008, the EndoBarrier is a very clever way to simulate the effect of a gastric bypass without the unpleasant scalpel part. It looks like a long clear plastic stocking, and it's simply threaded through the patient's mouth and stomach, down to the small intestine, where it lines the intestine's upper section (the same part that is bypassed in traditional surgery). Food slips right through it, but digestive enzymes are trapped on its other side. The two don't get to join forces until a couple of feet further downstream, so the effect on diabetes is a lot like that of a bypass: It resolves the symptoms of type 2 diabetes.

Fatal error: Call to a member function getUrl() on a non-object in /home/diabetes/public_html/browse.php on line 54